Virus-Free Synthesis of a Hepatitis C Virus P7 cDNA through a Three-Steps Polymerase Chain Reaction

E. Zicca, N. Marascio, Grazia Pavia, Francesco Bombardiere, S. D’Agostino, Fern, A. Fabiani, A. Bilotta, N. Perrotti, F. Trapasso, M. Liberto, A. Focà
{"title":"Virus-Free Synthesis of a Hepatitis C Virus P7 cDNA through a Three-Steps Polymerase Chain Reaction","authors":"E. Zicca, N. Marascio, Grazia Pavia, Francesco Bombardiere, S. D’Agostino, Fern, A. Fabiani, A. Bilotta, N. Perrotti, F. Trapasso, M. Liberto, A. Focà","doi":"10.4172/2161-0703.1000239","DOIUrl":null,"url":null,"abstract":"Hepatitis C virus (HCV) infection represents a great public healthcare challenge as it affects nearly 170 million individuals worldwide. Therefore, the deep investigation of the mechanisms involved in the pathogenesis of chronic hepatitis induced by HCV is a crucial step in the design of novel targeted therapies for the treatment of this condition. However, techniques of molecular biology to characterize HCV proteins can suffer of intrinsic limitations due to high mutation rates of the virus genome. \nIn this study, we propose a novel strategy to synthesize a viral cDNA sequence corresponding to the p7 gene in HCV genome-free conditions. Our approach consists of a three-steps polymerase chain reactions (PCRs) by using a set of four large overlapping synthetic oligonucleotides aimed to separately amplify both 5’ and 3’ ends of the p7 gene; 5’ and 3’ products, overlapping themselves, were then used as a template in a third PCR amplification in order to get a full-length p7 cDNA. \nOur methodology represents an interesting proof-of-principle as it allows for the safe manipulation of short viral genes. Moreover, this new technique overcomes the elevated genetic variability of HCV genomes without affecting the antigenic characteristics of the putative viral protein.","PeriodicalId":269971,"journal":{"name":"Journal of Medical Microbiology and Diagnosis","volume":"53 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2016-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medical Microbiology and Diagnosis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2161-0703.1000239","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Hepatitis C virus (HCV) infection represents a great public healthcare challenge as it affects nearly 170 million individuals worldwide. Therefore, the deep investigation of the mechanisms involved in the pathogenesis of chronic hepatitis induced by HCV is a crucial step in the design of novel targeted therapies for the treatment of this condition. However, techniques of molecular biology to characterize HCV proteins can suffer of intrinsic limitations due to high mutation rates of the virus genome. In this study, we propose a novel strategy to synthesize a viral cDNA sequence corresponding to the p7 gene in HCV genome-free conditions. Our approach consists of a three-steps polymerase chain reactions (PCRs) by using a set of four large overlapping synthetic oligonucleotides aimed to separately amplify both 5’ and 3’ ends of the p7 gene; 5’ and 3’ products, overlapping themselves, were then used as a template in a third PCR amplification in order to get a full-length p7 cDNA. Our methodology represents an interesting proof-of-principle as it allows for the safe manipulation of short viral genes. Moreover, this new technique overcomes the elevated genetic variability of HCV genomes without affecting the antigenic characteristics of the putative viral protein.
通过三步聚合酶链反应无病毒合成丙型肝炎病毒P7 cDNA
丙型肝炎病毒(HCV)感染是一个巨大的公共卫生挑战,因为它影响了全世界近1.7亿人。因此,深入研究HCV诱导的慢性肝炎发病机制是设计新型靶向治疗方法的关键一步。然而,由于病毒基因组的高突变率,表征HCV蛋白的分子生物学技术可能受到内在的限制。在这项研究中,我们提出了一种在HCV无基因组条件下合成p7基因对应的病毒cDNA序列的新策略。我们的方法包括三步聚合酶链反应(pcr),通过使用一组四个大的重叠合成寡核苷酸,旨在分别扩增p7基因的5 '和3 '端;然后将重叠的5 '和3 '产物用作第三次PCR扩增的模板,以获得全长p7 cDNA。我们的方法代表了一个有趣的原理证明,因为它允许安全操作短病毒基因。此外,这种新技术克服了HCV基因组遗传变异的升高,而不影响假定的病毒蛋白的抗原特征。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信